Skip to main content
. 2021 Mar 25;17(1):24–35. doi: 10.14797/QIQG9041

Table 3. Summary of the outcomes comparing various surgical modalities for cardiac sympathetic denervation. The P value represents comparison of the surgical modality to all bilateral surgical cardiac sympathetic denervation. The asterisk indicates values reaching statistical significance or P < .05.

SURGICAL MODALITY

INCLUDED STUDIES (#)

PATIENTS DENERVATED

MEAN AGE (YEARS)

AGE RANGE (YEARS)

MEAN FOLLOW-UP (YEARS)

MEAN FOLLOW-UP RANGE (YEARS)

% MORTALITY/TRANSPLANT (95% CI)

MORTALITY/TRANSPLANT P VALUE

% ICD SHOCK-FREE AFTER DENERVATION (95% CI)

ICD SHOCK-FREE P VALUE

% ICD SHOCK-/TRANSPLANT-FREE SURVIVAL AFTER DENERVATION (95% CI)

ICD SHOCK-/TRANSPLANT-FREE SURVIVAL P VALUE

REFERENCES

All bilateral thoracoscopic denervation procedures (baseline)

12

161

53.38

20 to 80

1.24

0.19 to 1.9

19.3% (13.9-26.0)

n/a

59.0% (51.3-66.3)

n/a

10,11,14, 16,18,19,21, 23-26,29

Bilateral thoracoscopic denervation with lower half stellectomy T2-T4 ganglionectomy with Kuntz nerve division if identified

7

143

53.40

20 to 73

1.3

0.19 to 1.9

18.9% (13.3-26.0)

> .999

57.3% (49.1-65.2)

0.816

8,11,19,21,24,26,29

All left thoracoscopic denervation procedures

9

69

48.37

22 to 80

1.7

0.52 to 2.75

31.9% (22.1-43.6)*

.042*

53.6% (42.0-64.9)

0.47

8,12,15,17,22,23,27-29